A Sampling of Products We’ve Developed and Sell
ClearView Metrics is a health analytics software platform that serves persons suffering from chronic pain, behavioral health conditions and substance use disorders, and also serves their healthcare providers. Our client in this case is a medication monitoring / toxicology testing company serving large U.S. regions. The client sought to develop a market differentiator to enhance attractiveness of their service offerings. The Blue Star Medical Sales team worked to understand unmet needs of the client’s target customer base. From that we collaborated with our partner company Acumen Business Group (AcumenBG) to create a vision for a remote self-monitoring and analytics platform that integrates individual patient’s health status data with data from their routine lab test results. We worked with AcumenBG to develop the specification for the platform including a mobile phone app and web-based support portals, brought key partners together and led product development and sales launch. The result is ClearView Metrics. Healthcare providers can use its analytics to help guide better treatment decisions, identify and correct adverse trends, and increase the overall quality of their patients’ care.
The Naloxone Safety Kit combines the life-saving value of naloxone with safety materials that help protect individuals responding to an opioid emergency. Naloxone is a medication used to block the effects of opioids. It works by reversing the depression of the central nervous system and respiratory system caused by opioids, and can literally save lives when administered to a person experiencing an opioid overdose. While naloxone can save the person suffering the overdose, a person responding to the emergency may be at risk of exposure to pathogens and accidental contact with the overdose drug. Working with partner company AcumenBG, Blue Star Medical Sales designed the Naloxone Safety Kit (NSK), its instructional materials, labeling and sourced its contents. We led the process of getting the NSK registered with the U.S. Food and Drug Administration. We concentrated sales efforts on channels that make NSKs accessible near higher concentrations of at-risk individuals, and we are actively selling through those and other channels. We also work with sales points to identify sources of public and private funding as needed to help purchase NSKs. Our work and focus is dedicated to helping make NSKs accessible to at-risk individuals, protecting rescuers from exposure risks, and realizing Naloxone Safety Kit’s fundamental mission: save lives.